Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24211163 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Placebo;   Drug: Dasatinib;   Drug: Docetaxel;   Drug: Prednisone

Study has passed its completion date and status has not been verified in more than two years.